HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv
microRNA‐103a Functions as a Mechanosensitive microRNA to Inhibit Bone Formation Through Targeting Runx2 - Zuo - 2015 - Journal of Bone and Mineral Research - Wiley Online Library
SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines
The role of selenium in cell survival and its correlation with protective effects against cardiovascular disease: A literature review - ScienceDirect
Drug repositioning in cancer: The current situation in Japan - Masuda - 2020 - Cancer Science - Wiley Online Library
Cancers | Free Full-Text | Molecular and Cellular Mechanisms of Metformin in Cervical Cancer | HTML
mTOR: a pharmacologic target for autophagy regulation - Document - Gale OneFile: Health and Medicine
Metformin: An old drug against old age and associated morbidities - Diabetes Research and Clinical Practice
Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals - Journal of Molecular and Cellular Cardiology
Frontiers | Therapeutic vs. Suprapharmacological Metformin Concentrations: Different Effects on Energy Metabolism and Mitochondrial Function in Skeletal Muscle Cells in vitro
cybercamp-2015/alexaTop1mAXFRcommonSubdomains.fuzz.txt at master · abirtone/cybercamp-2015 · GitHub
HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv
Wonderlands 2015 - Akt Kalender schwarzweiss Foto & Bild | erwachsene, kinder und erwachsene, menschen Bilder auf fotocommunity
Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer* - Journal of Biological Chemistry
Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
Obesity and cancer, a case for insulin signaling | Cell Death & Disease
Genomics in acute lymphoblastic leukaemia: insights and treatment implications | Nature Reviews Clinical Oncology
Slow Aging and Delay Chronic Disease Development | William H Bestermann Jr MD | Substack
SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines | Cancer Genomics & Proteomics
Cancer stem cells, plasticity, and drug resistance
Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma | Science Signaling
